These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12793380)

  • 41. Fuzeon combination highly effective.
    AIDS Patient Care STDS; 2006 Dec; 20(12):888. PubMed ID: 17219619
    [No Abstract]   [Full Text] [Related]  

  • 42. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). T-1249 for T-20 salvage.
    Feinberg J
    AIDS Clin Care; 2003 Nov; 15(11):95-6. PubMed ID: 14682275
    [No Abstract]   [Full Text] [Related]  

  • 43. HIV/AIDS. Report of novel treatment aimed at latent HIV raises the 'c word'.
    Cohen J
    Science; 2005 Aug; 309(5737):999-1000. PubMed ID: 16099956
    [No Abstract]   [Full Text] [Related]  

  • 44. New class of anti-HIV drugs.
    Stephenson J
    JAMA; 1999 Dec; 282(21):1994. PubMed ID: 10591371
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid.
    van Lelyveld SF; Nijhuis M; Baatz F; Wilting I; van den Bergh WM; Kurowski M; de Jong D; Hoepelman AI; Wensing AM
    Clin Infect Dis; 2010 Feb; 50(3):387-90. PubMed ID: 20047481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-HIV agents. Access denied--keeping HIV out with entry inhibitors.
    TreatmentUpdate; 2006; 18(4):4. PubMed ID: 17205653
    [No Abstract]   [Full Text] [Related]  

  • 47. Enfuvirtide.
    LaBonte J; Lebbos J; Kirkpatrick P
    Nat Rev Drug Discov; 2003 May; 2(5):345-6. PubMed ID: 12755128
    [No Abstract]   [Full Text] [Related]  

  • 48. Anti-HIV agents. Valproic acid and HIV eradication--many questions remain.
    TreatmentUpdate; 2005; 17(6):5-7. PubMed ID: 17228476
    [No Abstract]   [Full Text] [Related]  

  • 49. HIV fusion inhibitors.
    Pozniak A
    J HIV Ther; 2001 Nov; 6(4):91-4. PubMed ID: 11740409
    [No Abstract]   [Full Text] [Related]  

  • 50. Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies.
    Negredo E; Bonjoch A; Paredes R; Puig J; Clotet B
    Clin Infect Dis; 2005 Sep; 41(6):901-5. PubMed ID: 16107993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV entry inhibitors: progress in development and application.
    Lai WH; Huang L; Chen CH
    Yao Xue Xue Bao; 2010 Feb; 45(2):131-40. PubMed ID: 21348414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-HIV agents. T-20 shows long-term effectiveness and safety.
    TreatmentUpdate; 2005; 17(5):8-9. PubMed ID: 17225280
    [No Abstract]   [Full Text] [Related]  

  • 53. A T-20 diary.
    Gormley F
    GMHC Treat Issues; 2002 Mar; 16(3):6-7. PubMed ID: 12004799
    [No Abstract]   [Full Text] [Related]  

  • 54. Looking within.
    Sahm J
    Res Initiat Treat Action; 2005; 11(2):5-6. PubMed ID: 16456973
    [No Abstract]   [Full Text] [Related]  

  • 55. T-20: a model for novel anti-HIV drugs in development.
    Laurence J
    AIDS Read; 2002 Nov; 12(11):469-70. PubMed ID: 12494906
    [No Abstract]   [Full Text] [Related]  

  • 56. T-20 and adefovir for salvage therapy -- expect no miracles.
    Gilden D
    GMHC Treat Issues; 1998 Apr; 12(4):6-7. PubMed ID: 11365400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen.
    Deeks SG; Lu J; Hoh R; Neilands TB; Beatty G; Huang W; Liegler T; Hunt P; Martin JN; Kuritzkes DR
    J Infect Dis; 2007 Feb; 195(3):387-91. PubMed ID: 17205477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. T-20 salvage results hold up at 48 weeks.
    Feinberg J
    AIDS Clin Care; 2003 Sep; 15(9):77-8. PubMed ID: 14666913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enfuvirtide, a new treatment for HIV infection.
    Moledina S; Boucher M
    Issues Emerg Health Technol; 2003 Oct; (50):1-6. PubMed ID: 14594020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
    Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.